CN113287703A - 一种舞茸绣球菌多糖小肽固体饮料及其生产方法 - Google Patents
一种舞茸绣球菌多糖小肽固体饮料及其生产方法 Download PDFInfo
- Publication number
- CN113287703A CN113287703A CN202110257205.8A CN202110257205A CN113287703A CN 113287703 A CN113287703 A CN 113287703A CN 202110257205 A CN202110257205 A CN 202110257205A CN 113287703 A CN113287703 A CN 113287703A
- Authority
- CN
- China
- Prior art keywords
- small peptide
- sparassis crispa
- powder
- polysaccharide
- maitake mushroom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000272503 Sparassis radicata Species 0.000 title claims abstract description 72
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 51
- 150000004676 glycans Chemical class 0.000 title claims abstract description 46
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 46
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 46
- 235000013361 beverage Nutrition 0.000 title claims abstract description 23
- 239000007787 solid Substances 0.000 title claims abstract description 23
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 14
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims abstract description 71
- 240000001080 Grifola frondosa Species 0.000 claims abstract description 65
- 235000007710 Grifola frondosa Nutrition 0.000 claims abstract description 65
- 239000000843 powder Substances 0.000 claims abstract description 45
- 102000008186 Collagen Human genes 0.000 claims abstract description 8
- 108010035532 Collagen Proteins 0.000 claims abstract description 8
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 8
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 8
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 8
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 8
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 8
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 8
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 8
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 8
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 8
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 8
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 8
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims abstract description 8
- 229920001436 collagen Polymers 0.000 claims abstract description 8
- 229940013618 stevioside Drugs 0.000 claims abstract description 8
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims abstract description 8
- 235000019202 steviosides Nutrition 0.000 claims abstract description 8
- 238000001694 spray drying Methods 0.000 claims description 18
- 244000045195 Cicer arietinum Species 0.000 claims description 15
- 235000010523 Cicer arietinum Nutrition 0.000 claims description 15
- 238000003756 stirring Methods 0.000 claims description 15
- 241000233866 Fungi Species 0.000 claims description 14
- 238000001914 filtration Methods 0.000 claims description 13
- 239000002002 slurry Substances 0.000 claims description 13
- 239000012528 membrane Substances 0.000 claims description 12
- 230000032683 aging Effects 0.000 claims description 11
- 238000000227 grinding Methods 0.000 claims description 11
- 239000004365 Protease Substances 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 10
- 239000000413 hydrolysate Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000008213 purified water Substances 0.000 claims description 8
- 102000004190 Enzymes Human genes 0.000 claims description 7
- 108090000790 Enzymes Proteins 0.000 claims description 7
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 7
- 238000006243 chemical reaction Methods 0.000 claims description 7
- 229940088598 enzyme Drugs 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 238000007670 refining Methods 0.000 claims description 7
- 238000012216 screening Methods 0.000 claims description 7
- 108090000145 Bacillolysin Proteins 0.000 claims description 5
- 108091005658 Basic proteases Proteins 0.000 claims description 5
- 108010004032 Bromelains Proteins 0.000 claims description 5
- 108091005507 Neutral proteases Proteins 0.000 claims description 5
- 102000035092 Neutral proteases Human genes 0.000 claims description 5
- 108090000526 Papain Proteins 0.000 claims description 5
- 235000019835 bromelain Nutrition 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 150000002500 ions Chemical class 0.000 claims description 5
- 235000019834 papain Nutrition 0.000 claims description 5
- 229940055729 papain Drugs 0.000 claims description 5
- 241000123241 Sparassis Species 0.000 claims description 4
- 230000000415 inactivating effect Effects 0.000 claims description 4
- 238000007873 sieving Methods 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 2
- 230000009849 deactivation Effects 0.000 claims description 2
- 238000007599 discharging Methods 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- 235000017550 sodium carbonate Nutrition 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 11
- 210000004369 blood Anatomy 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 6
- 230000036039 immunity Effects 0.000 abstract description 5
- 235000015097 nutrients Nutrition 0.000 abstract description 5
- 230000036772 blood pressure Effects 0.000 abstract description 4
- 230000001737 promoting effect Effects 0.000 abstract description 4
- 210000000577 adipose tissue Anatomy 0.000 abstract description 3
- 210000000988 bone and bone Anatomy 0.000 abstract description 3
- 238000000605 extraction Methods 0.000 abstract description 3
- 230000003907 kidney function Effects 0.000 abstract description 3
- 230000004060 metabolic process Effects 0.000 abstract description 3
- 238000005728 strengthening Methods 0.000 abstract description 3
- 210000002435 tendon Anatomy 0.000 abstract description 3
- 238000013329 compounding Methods 0.000 abstract 1
- 229920001503 Glucan Polymers 0.000 description 9
- 239000000047 product Substances 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 229920002498 Beta-glucan Polymers 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 239000000084 colloidal system Substances 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 3
- 235000017491 Bambusa tulda Nutrition 0.000 description 3
- 108090000288 Glycoproteins Proteins 0.000 description 3
- 102000003886 Glycoproteins Human genes 0.000 description 3
- 244000082204 Phyllostachys viridis Species 0.000 description 3
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 3
- 229920001231 Polysaccharide peptide Polymers 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 102000019197 Superoxide Dismutase Human genes 0.000 description 3
- 108010012715 Superoxide dismutase Proteins 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000011425 bamboo Substances 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 108010022457 polysaccharide peptide Proteins 0.000 description 3
- 238000004064 recycling Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000002893 slag Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- FYGDTMLNYKFZSV-WFYNLLPOSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,3s,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-WFYNLLPOSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 229940091258 selenium supplement Drugs 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 241001327634 Agaricus blazei Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010006272 Breast mass Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 235000001715 Lentinula edodes Nutrition 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 240000005819 Magnolia denudata Species 0.000 description 1
- 235000016094 Magnolia denudata Nutrition 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000121220 Tricholoma matsutake Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 208000005368 osteomalacia Diseases 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/723—Xanthans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
一种舞茸绣球菌多糖小肽固体饮料及其生产方法,属于食用菌多糖与小肽营养成分的提取技术领域,属于生物技术,是将鲜舞茸、鲜绣球菌洗净后,经磨浆、老化,再经酶解反应、灭酶活后,分离过滤收集滤液,对滤液进行精密过滤,得到食用菌提取液,所得食用菌提取液经膜精制浓缩、喷雾干燥、筛分后得到舞茸绣球菌多糖小肽粉。再将舞茸绣球菌多糖小肽粉、山楂粉、VC、黄胶原、菊糖苷按比例复配得到固体饮料产品。本发明固体饮料组分配伍合理,能有效发挥各组分的作用,组合后的产品对于改善亚健康人群,尤其是提高免疫力,快速抗疲劳,改善睡眠,降血脂、降血压、降血糖、促进体脂代谢、补血、强筋壮骨、提高肾功能等方面,有很好的保健效果。
Description
技术领域
本发明属于食用菌多糖与小肽营养成分的提取以及固体饮料制备技术领域,属于生物技术,具体是指一种舞茸绣球菌小肽多糖及其固体饮料的生产方法。
背景技术
食用菌含有丰富的营养物质,是保健产品的宝库。舞茸(灰树花)、绣球菌是其中的极品。
舞茸,又称灰树花,是食、药兼用蕈菌,其外观,婀娜多姿、层叠似菊;菇味清香的珍稀菌品。号称“百菇之王”,其气味、清香四溢,沁人心脾;舞茸肉质脆嫩爽口,且久煮口感仍保持脆嫩,汤汁饱满,风味独特;其具有很好的保健作用和很高的药用价值。多年以来,作为高级保健食品,风靡日本及欧美等国家,在日本其被评为仅次于松茸的极品菇菌。舞茸具有松木芳香,肉质柔嫩,味如鸡丝,脆似玉兰。
舞茸富含Maitake D-fraction(舞茸D-fraction)多糖,人体必需氨基酸和微量元素,维生素B1,蛋白质和氨基酸含量是香菇的两倍。舞茸本身富有机硒,可作为补硒食品,并且其富含赖氨酸和精氨酸,对妊娠哺乳期妇女和儿童尤其显著,可以促进胎儿智力发育,使婴儿更聪明健壮。
舞茸富含优质蛋白、氨基酸、维生素、膳食纤维等,现代科学已从分子水平上证实了舞茸的营养保健功能及其药用价值。蛋白质是舞茸中高含量的功能性成分,舞茸蛋白中含有18种氨基酸,其中8种是人体必需的氨基酸,特别是色氨酸含量很高,对于平衡人体的营养成分具有重要作用。
绣球菌含有大量β葡聚糖。绣球菌的最大特点是含有大量β葡聚糖。根据日本食品分析中心的分析,每100g绣球菌含有β-葡聚糖高达43.6g,比灵芝和姬松茸高出3~4倍。可以说,绣球菌所含的β-葡聚糖为菇类之最。葡聚糖是由葡萄糖单体聚合而成的多糖,分为α型和β型,α型葡聚糖如淀粉等,是机体能量的主要来源,不具备生物活性。β型葡聚糖是一种生物活性物质,经医学研究证实,具有免疫调节、抗肿瘤、抗炎、抗病毒、抗氧化、抗辐射、降血糖、降血脂、保肝等多种功能。研究还发现,大多数具有抗肿瘤活性的多糖都是带有β(1-6)糖苷键分支的β(1-3)D葡聚糖。有研究证明,来自真菌的β(1-3)D葡聚糖通常具有抑制肿瘤作用。
绣球菌中的葡聚糖70%以上是β(1-3)D葡聚糖,具有良好的抗肿瘤、免疫调节以及提高造血功能等功效。绣球菌含有大量维生素和矿物质,绣球菌含有维生素C、维生素E,其维生素E含量位居菌藻类食物前列,这些维生素具有抗氧化作用。绣球菌还含有麦角固醇,在阳光和紫外线照射下可转变为维生素D,能促进钙磷吸收,有利于骨骼形成,预防儿童佝偻病、成人骨质疏松症和骨质软化症。绣球菌含有相当高的钾元素,而钠的含量较低,这种高钾低钠食品有利尿作用,对高血压患者十分有益。
绣球菌含有大量抗氧化物质人体内的自由基会引起生物细胞氧化性损伤而导致机体老化,并破坏机体的抗病、防御能力、导致癌症和心血管疾病等慢性病。如今,天然食物的抗氧化能力已经受到人们的普遍重视,其中,超氧化物歧化酶(SOD)能有效清除体内的自由基,防止活性氧对机体的伤害,抗氧化、抗衰老的作用。据测定,绣球菌中超氧化物歧化酶的含量位居各种食用菌之首。
舞茸、绣球菌富含多糖成分,尤其是舞茸、绣球菌不同于其它菇类的特别多糖组分。包括X-组分(β-D-葡聚糖,尤其是高分支β-1,3/1,6-D-葡聚糖分支结构,和SX-D组分(超级β-D-葡聚糖蛋白),赋予舞茸优于所有菇类特别的医疗与保健性能。与酵母葡聚糖相比性能更优越。
舞茸、绣球菌营养成分的提取方法,大多是采用直接提取多糖成分的水提方法,其缺点是舞茸成分中蛋白质占15%以上,绣球菌也含有4%以上的蛋白质,大部分功能性多糖以糖蛋白的形式存在,大部分糖蛋白分子量大难以直接水提,损失许多营养成分,大大降低了舞茸的保健效果。
发明内容
本发明的目的,是提供一种舞茸、绣球菌多糖小肽固体饮料的制备方法。本发明所用原料是鲜舞茸、鲜绣球菌。该固体饮料是由舞茸绣球菌多糖小肽粉、山楂粉、VC、黄胶原、菊糖苷按比例合理配置而成。同时本发明还提供了一种专用于本发明固体饮料的舞茸绣球菌多糖小肽粉的生产方法。
为实现上述的发明目的,本发明采取的实施方式如下:
一种舞茸绣球菌多糖小肽固体饮料,其组成及组分的百分比含量是:
舞茸绣球菌多糖小肽粉:91~93.5%;
山楂粉:2.5~3.5%;
VC:2.5~3.5%;
黄胶原:1~1.5%;
菊糖苷:0.2~0.5%。
一种权利要求1或2中的舞茸绣球菌多糖小肽粉的生产方法,是将鲜舞茸、鲜绣球菌洗净后,经磨浆、老化,再经酶解反应、灭酶活后,分离过滤收集滤液,对滤液进行精密过滤,得到食用菌提取液,所得食用菌提取液经膜精制浓缩、喷雾干燥、筛分后得到舞茸绣球菌多糖小肽粉。
进一步的,磨浆步骤是用胶体磨将鲜舞茸、绣球菌、纯净水按照2:1:6的比例,磨浆,磨两遍。
进一步的,老化步骤是将上述浆液放入反应釜中,95℃,老化10分钟。
进一步的,酶解步骤是:降温至55℃,先用纯碱将浆液调节pH=8.5~9.5,加入鲜舞茸、绣球菌总重量0.3%的的碱性蛋白酶,在50~55℃搅拌反应2小时;再加入鲜舞茸、绣球菌总重量0.3%的中性蛋白酶,调节pH=6.5~7.5,在50~55℃搅拌反应2小时;之后调节pH=4~6.5,加入鹰嘴豆重量0.3%菠萝蛋白酶或和木瓜蛋白酶在50~75℃搅拌反应8小时。
进一步的,灭酶活是升温至95℃,10分钟。
进一步的,膜精制浓缩是采用膜过滤器,先脱除鹰嘴豆小肽水解液中的一价和二价离子,降低其电导率;之后进行浓缩脱水,得到浓缩的提取液。
进一步的,喷雾干燥是采用喷雾干燥塔进行,干燥塔进料温度160~180℃,出料90~110℃,得到舞茸绣球菌多糖小肽喷雾干燥粉。
进一步的,筛分是采用60目超声波振动筛筛分,收集过60目筛的粉。
本发明的有益效果是:
1、本发明所用原料是鲜舞茸、鲜绣球菌制备而成,将舞茸、绣球菌中所含蛋白质转化成小分子肽,糖蛋白转化成多糖肽,同时提取其中的特别多糖成分和水溶性维生素、矿物质等营养成分,作为固体饮料的主体功能原料。
2、用上述方法制备的固体饮料,不仅保留了舞茸、绣球菌的保健功能,而且增加了小肽的保健功能,使其在增强免疫力、降脂减肥、降压、降糖、清肠刮肚、抗乳腺结节、抗癌、癌症预防等方面性能突出的天然的食用菌保健产品。
3、本发明固体饮料组分配伍合理,能有效发挥各组分的作用,组合后的产品对于改善亚健康人群,尤其是提高免疫力,快速抗疲劳,改善睡眠,降血脂、降血压、降血糖、促进体脂代谢、补血、强筋壮骨、提高肾功能等方面,有很好的保健效果。
本发明产品根据国家标准《GB/T22492-2008大豆肽粉》相应的方法及步骤检测,指标符合该标准要求。
具体实施方式
以下结合实施例,对依据本发明提供的具体实施方式详述如下:
实施例1
选用洗掉泥,去根的鲜舞茸400kg、鲜绣球菌200kg,在不锈钢槽子里用纯净水冲洗一遍,沥水;
磨浆:用胶体磨将鲜舞茸、绣球菌、纯净水按照用量份数2:1:6的比例,磨浆,磨两遍;
老化:将上述浆液放入两吨反应釜中,加纯净水到浆液2吨。95℃,老化10分钟;
酶解:降温至55℃,先用纯碱将浆液调节pH=8.5,加入鲜舞茸、绣球菌总重量0.3%的的碱性蛋白酶,在50℃搅拌反应2小时;再加入鲜舞茸、绣球菌总重量0.3%的中性蛋白酶,调节pH=6.5,在50℃搅拌反应2小时;之后调节pH=4,加入鹰嘴豆重量0.3%菠萝蛋白酶或和木瓜蛋白酶在55℃搅拌反应8小时;
灭酶活:升温至95℃,10分钟;
分离过滤:采用蝶式离心过滤机,将食用菌渣分离出去,收集滤液;渣烘干回收利用;
精密过滤:采用精密竹式硅藻土过滤机,对上述滤液进行精密过滤,得到食用菌提取液;
膜精制浓缩:采用膜过滤器,先脱除鹰嘴豆小肽水解液中的一价和二价离子,降低其电导率;之后进行浓缩脱水,得到浓缩的提取液;
喷雾干燥:采用喷雾干燥塔进行喷雾干燥,干燥塔进料温度160℃,出料90℃,得到舞茸绣球菌多糖小肽喷雾干燥粉;
筛分:得到的粉,采用60目超声波振动筛筛分,收集过60目筛的粉,舞茸绣球菌多糖小肽粉;
固体饮料制作:按照下列比例配制固体饮料:
舞茸绣球菌多糖小肽粉:92.8%
山楂粉:3%
VC:3%
黄胶原:1%
菊糖苷:0.2%
上述原料用V型混料机混料;装袋,包装,得到成品。
实施例2
选用洗掉泥,去根的鲜舞茸400kg、鲜绣球菌200kg,在不锈钢槽子里用纯净水冲洗一遍,沥水;
磨浆:用胶体磨将鲜舞茸、绣球菌、纯净水按照2:1:6的比例,磨浆,磨两遍;
老化:将上述浆液放入两吨反应釜中,加纯净水到浆液2吨。95℃,老化10分钟;
酶解:降温至55℃,先用纯碱将浆液调节pH=9.5,加入鲜舞茸、绣球菌总重量0.3%的的碱性蛋白酶,在55℃搅拌反应2小时;再加入鲜舞茸、绣球菌总重量0.3%的中性蛋白酶,调节pH=7.5,在55℃搅拌反应2小时;之后调节pH=6.5,加入鹰嘴豆重量0.3%菠萝蛋白酶或和木瓜蛋白酶在55℃搅拌反应8小时;
灭酶活:升温至95℃,10分钟;
分离过滤:采用蝶式离心过滤机,将食用菌渣分离出去,收集滤液;渣烘干回收利用;
精密过滤:采用精密竹式硅藻土过滤机,对上述滤液进行精密过滤,得到食用菌提取液;
膜精制浓缩:采用膜过滤器,先脱除鹰嘴豆小肽水解液中的一价和二价离子,降低其电导率;之后进行浓缩脱水,得到浓缩的提取液;
喷雾干燥:采用喷雾干燥塔进行喷雾干燥,干燥塔进料温度180℃,出料110℃,得到舞茸绣球菌多糖小肽喷雾干燥粉;
筛分:得到的粉,采用60目超声波振动筛筛分,收集过60目筛的粉,舞茸绣球菌多糖小肽粉;
固体饮料制作:按照下列比例配制固体饮料:
舞茸绣球菌多糖小肽粉:91%
山楂粉:3.5%
VC:3.5%
黄胶原:1.5%
菊糖苷:0.5%
上述原料用V型混料机混料;装袋,包装,得到成品。
实施例3
选用洗掉泥,去根的鲜舞茸400kg、鲜绣球菌200kg,在不锈钢槽子里用纯净水冲洗一遍,沥水;
磨浆:用胶体磨将鲜舞茸、绣球菌、纯净水按照2:1:6的比例,磨浆,磨两遍;
老化:将上述浆液放入两吨反应釜中,加纯净水到浆液2吨。95℃,老化10分钟;
酶解:降温至55℃,先用纯碱将浆液调节pH=9.0,加入鲜舞茸、绣球菌总重量0.3%的的碱性蛋白酶,在53℃搅拌反应2小时;再加入鲜舞茸、绣球菌总重量0.3%的中性蛋白酶,调节pH=7.0,在53℃搅拌反应2小时;之后调节pH=5.0,加入鹰嘴豆重量0.3%菠萝蛋白酶或和木瓜蛋白酶在60℃搅拌反应8小时;
灭酶活:升温至95℃,10分钟;
分离过滤:采用蝶式离心过滤机,将食用菌渣分离出去,收集滤液;渣烘干回收利用;
精密过滤:采用精密竹式硅藻土过滤机,对上述滤液进行精密过滤,得到食用菌提取液;
膜精制浓缩:采用膜过滤器,先脱除鹰嘴豆小肽水解液中的一价和二价离子,降低其电导率;之后进行浓缩脱水,得到浓缩的提取液;
喷雾干燥:采用喷雾干燥塔进行喷雾干燥,干燥塔进料温度170℃,出料100℃,得到舞茸绣球菌多糖小肽喷雾干燥粉;
筛分:得到的粉,采用60目超声波振动筛筛分,收集过60目筛的粉,舞茸绣球菌多糖小肽粉;
固体饮料制作:按照下列比例配制固体饮料:
舞茸绣球菌多糖小肽粉:93.5%
山楂粉:2.5%
VC:2.5%
黄胶原:1.2%
菊糖苷:0.3%
上述原料用V型混料机混料;装袋,包装,得到成品。
需要说明的是,本发明固体饮料组分配伍合理,能有效发挥各组分的作用,组合后的产品对于改善亚健康人群,尤其是提高免疫力,快速抗疲劳,改善睡眠,降血脂、降血压、降血糖、促进体脂代谢、补血、强筋壮骨、提高肾功能等方面,有很好的保健效果。上述实施例并非是对本发明技术方案保护范围的限制,对于属于本发明技术构思,并属于显而易见的调整及改动,均应属于本发明保护范围之内。
Claims (10)
1.一种舞茸绣球菌多糖小肽固体饮料,其组成及组分的百分比含量是:
舞茸绣球菌多糖小肽粉:91~93.5%;
山楂粉:2.5~3.5%;
VC:2.5~3.5%;
黄胶原:1~1.5%;
菊糖苷:0.2~0.5%。
2.根据权利要求1所述的舞茸绣球菌多糖小肽固体饮料,其特征是:其组成及组分的百分比含量是:
舞茸绣球菌多糖小肽粉:92.8%;
山楂粉:3%;
VC:3%;
黄胶原:1%;
菊糖苷:0.2%。
3.一种权利要求1或2中的舞茸绣球菌多糖小肽粉的生产方法,其特征是:将鲜舞茸、鲜绣球菌洗净后,经磨浆、老化,再经酶解反应、灭酶活后,分离过滤收集滤液,对滤液进行精密过滤,得到食用菌提取液,所得食用菌提取液经膜精制浓缩、喷雾干燥、筛分后得到舞茸绣球菌多糖小肽粉。
4.根据权利要求3所述的舞茸绣球菌多糖小肽粉的生产方法,其特征是:磨浆步骤是用胶体磨将鲜舞茸、绣球菌、纯净水按照2:1:6的比例,磨浆,磨两遍。
5.根据权利要求3所述的舞茸绣球菌多糖小肽粉的生产方法,其特征是:老化步骤是将上述浆液放入反应釜中,95℃,老化10分钟。
6.根据权利要求3所述的舞茸绣球菌多糖小肽粉的生产方法,其特征是:酶解步骤是:降温至55℃,先用纯碱将浆液调节pH=8.5~9.5,加入鲜舞茸、绣球菌总重量0.3%的的碱性蛋白酶,在50~55℃搅拌反应2小时;再加入鲜舞茸、绣球菌总重量0.3%的中性蛋白酶,调节pH=6.5~7.5,在50~55℃搅拌反应2小时;之后调节pH=4~6.5,加入鹰嘴豆重量0.3%菠萝蛋白酶或和木瓜蛋白酶在50~75℃搅拌反应8小时。
7.根据权利要求3所述的舞茸绣球菌多糖小肽粉的生产方法,其特征是:灭酶活是升温至95℃,10分钟。
8.根据权利要求3所述的舞茸绣球菌多糖小肽粉的生产方法,其特征是:膜精制浓缩是采用膜过滤器,先脱除鹰嘴豆小肽水解液中的一价和二价离子,降低其电导率;之后进行浓缩脱水,得到浓缩的提取液。
9.根据权利要求3所述的舞茸绣球菌多糖小肽粉的生产方法,其特征是:喷雾干燥:采用喷雾干燥塔进行喷雾干燥,干燥塔进料温度160~180℃,出料90~110℃,得到舞茸绣球菌多糖小肽喷雾干燥粉。
10.根据权利要求3所述的舞茸绣球菌多糖小肽粉的生产方法,其特征是:筛分是采用60目超声波振动筛筛分,收集过60目筛的粉。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110257205.8A CN113287703A (zh) | 2021-03-10 | 2021-03-10 | 一种舞茸绣球菌多糖小肽固体饮料及其生产方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110257205.8A CN113287703A (zh) | 2021-03-10 | 2021-03-10 | 一种舞茸绣球菌多糖小肽固体饮料及其生产方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113287703A true CN113287703A (zh) | 2021-08-24 |
Family
ID=77319200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110257205.8A Pending CN113287703A (zh) | 2021-03-10 | 2021-03-10 | 一种舞茸绣球菌多糖小肽固体饮料及其生产方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113287703A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113826898A (zh) * | 2021-08-26 | 2021-12-24 | 闽江学院 | 一种绣球菌β-葡聚糖微胶囊及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101869264A (zh) * | 2010-06-02 | 2010-10-27 | 文承官 | 含有β-葡聚糖的菌菇浓缩液品、饮料及制备方法 |
CN102078340A (zh) * | 2010-12-23 | 2011-06-01 | 孙婷婷 | 蛋白营养制品及其制备方法和应用 |
CN102199647A (zh) * | 2011-03-25 | 2011-09-28 | 梅跃明 | 一种利用食用菌副产物分离提取活性肽的方法 |
CN111011833A (zh) * | 2019-12-23 | 2020-04-17 | 惠州市润树农业科技有限公司 | 灰树花粉的加工工艺和灰树花粉固体饮料 |
-
2021
- 2021-03-10 CN CN202110257205.8A patent/CN113287703A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101869264A (zh) * | 2010-06-02 | 2010-10-27 | 文承官 | 含有β-葡聚糖的菌菇浓缩液品、饮料及制备方法 |
CN102078340A (zh) * | 2010-12-23 | 2011-06-01 | 孙婷婷 | 蛋白营养制品及其制备方法和应用 |
CN102199647A (zh) * | 2011-03-25 | 2011-09-28 | 梅跃明 | 一种利用食用菌副产物分离提取活性肽的方法 |
CN111011833A (zh) * | 2019-12-23 | 2020-04-17 | 惠州市润树农业科技有限公司 | 灰树花粉的加工工艺和灰树花粉固体饮料 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113826898A (zh) * | 2021-08-26 | 2021-12-24 | 闽江学院 | 一种绣球菌β-葡聚糖微胶囊及其制备方法 |
CN113826898B (zh) * | 2021-08-26 | 2023-11-03 | 闽江学院 | 一种绣球菌β-葡聚糖微胶囊及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103719880B (zh) | 高活性紫甘薯膳食纤维的制备方法 | |
CN108085356A (zh) | 以低温压榨核桃粕为原料工业化生产高纯度核桃肽的方法 | |
CN108713761A (zh) | 一种多功能复合低聚肽营养粉及其制备方法 | |
CN105901705A (zh) | 一种食用菌多糖和富硒米蛋白肽复配制剂及其制备方法 | |
CN107177656A (zh) | 一种泥鳅鱼蛋白多肽及其应用 | |
CN102994598A (zh) | 丙氨酸和亮氨酸含量高的弱苦味玉米低聚肽及其制备方法 | |
CN105054079B (zh) | 一种甘薯加工利用方法 | |
CN106689948A (zh) | 一种胶原蛋白复合亚麻酸饮料及其制备方法 | |
CN104877035A (zh) | 一种具有降糖作用的黑木耳多糖的制备方法 | |
CN105249106A (zh) | 一种复合发酵饮料及其制备方法 | |
CN111011833A (zh) | 灰树花粉的加工工艺和灰树花粉固体饮料 | |
CN113287703A (zh) | 一种舞茸绣球菌多糖小肽固体饮料及其生产方法 | |
CN109170888A (zh) | 一种抗氧化、抗疲劳组合物及其制备方法 | |
CN105707404A (zh) | 一种金丝小枣枣多肽生产方法 | |
CN109384858A (zh) | 一种富硒菊芋硒多糖的提取制备方法 | |
KR20200023053A (ko) | 베타글루칸 분말, 키토산 분말, 아세로라 추출분말, 영지버섯자실체 추출분말, 잎새버섯 분말, 표고버섯균사체 분말, 구기자 분말, 알로에 분말, 당귀 추출분말 및 인삼 추출분말을 포함하는 분말 형태의 종합영양보조식품 | |
CN104305181A (zh) | 竹荪复合保健饮品制作工艺 | |
CN108967900A (zh) | 一种富硒增健粉及其制备方法 | |
CN114128812A (zh) | 一种即饮型易消化牛蒡燕窝肽液复合饮品及其制备方法 | |
CN107319527A (zh) | 利用玉竹制备大鲵营养粉产品 | |
CN112813125A (zh) | 一种核桃肽的制备方法 | |
CN106036605A (zh) | 一种蓝莓果粉产品及其制备方法 | |
CN108634313B (zh) | 一种红薯茎叶高营养活性提取物及其制备方法 | |
CN1374036A (zh) | 食药用真菌与水果混合酿制保健品和医药及新方法 | |
CN105440101B (zh) | 一种富含多酚荞麦浓缩蛋白的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |